Chief Operating And Business Officer
CurrentOramed Pharmaceuticals (NASDAQ/TASE:ORMP) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. Through its patented flagship product, an orally ingestible insulin capsule currently in late-stage Phase 2 trials under the USFDA, the Company is seeking to revolutionize the treatment of diabetes.Responsibilities included: * Member of senior management team* Responsible for all day-to-day operations which included design and build out of new facility* Responsible for operations of clinical studies in the US and Israel (multiple multi-center Phase 2b FDA studies)* Building internal processes for multi-disciplinary interaction* Negotiating and managing the contractual/financing processes - Raised >$70M in SPAs/RDs - Successfully completed transformative (out)license of technology to Chinese partner ($50M + royalties) – Largest China-Israel Pharma deal - Post deal alliance management * Heading up all investor relations activities including road shows to the US, Far East and EU